Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02661620 · ClinicalTrials.gov registry record
REDAPT Retrospective-Prospective Modular Stem Study
A clinical trial, sponsored by Smith & Nephew.
- Terminated
- Registry status
- 140
- Enrollment target
NCT02661620 is a clinical trial that was terminated before completion, run by Smith & Nephew. The registered enrollment target is 140 participants.
The verdict
NCT02661620 was terminated before completion, sponsored by Smith & Nephew.
- TERMINATED
- Registry status
- 140 participants
- Enrollment target
Study Summary
A Retrospective-Prospective Study of REDAPT Revision Femoral System Modular Stem is a post-market, retrospective-prospective, multi-center, single arm, consecutive series study design to provide data on the post market performance and safety of the study device. The study will collect retrospective data from medical records review and prospective data from observations data at 5 and 10 postoperatively clinical visits. There will also be a 7.5 year telephone follow up contact to assess for device status and adverse events.
Interventions
- DEVICE REDAPT Revision Femoral System modular stem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2016-02 |
| Est. Completion | 2020-04-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02661620
The ClinicalTrials.gov registry entry for NCT02661620 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which REDAPT Revision Femoral System modular stem is the first listed.
NCT02661620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02661620 about?
NCT02661620 is a clinical study titled "REDAPT Retrospective-Prospective Modular Stem Study". A Retrospective-Prospective Study of REDAPT Revision Femoral System Modular Stem is a post-market, retrospective-prospective, multi-center, single arm, consecutive series study design to provide data on the post market performance and safety of the study device. The study will collect retrospective ...
What is the current status of trial NCT02661620?
This trial is currently terminated. The enrollment target is 140 participants. The study started on 2016-02. Estimated completion is 2020-04-16.
What interventions are being tested in trial NCT02661620?
The interventions under investigation include: REDAPT Revision Femoral System modular stem (DEVICE).
Who is sponsoring clinical trial NCT02661620?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.